Biofeedback Pain Relief Device First of its Kind to be Registered with FDA - After passing its preliminary registration phase with the FDA, Ondamed is now awaiting final approval to be officially listed with the government agency as an effective pain-treatment device. The cutting-edge device is already receiving great feedback from both patients and doctors, says Silvia Locke (CEO and president of the company), who adds that it is increasingly being recognized in the health community as a viable alternative to painkillers. Practitioners are also finding that ONDAMED® is helpful in relieving the symptoms of Lyme disease and trigeminal neuralgia. Lyme, like trigeminal neuralgia, is a disease that is dreadfully debilitating and for which people have great difficulty in getting effective treatment.
"I am very impressed with ONDAMED®," says Burton Goldberg, Ph.
|
Businessportal24
|
International Press Release Publishing for free in 15 languages across 22 countries
|
Forgot your password?